##plugins.themes.academic_pro.article.main##
Abstract
This article presents the results of a study of 129 patients with type 2 diabetes and 110 healthy people to determine whether the polymorphic markers AluIns / Dell> D of the ACE gene are associated with the development of diabetic nephropathy (DN). Patients in the main group: 65 patients with a disease duration of up to 10 years, without diabetic nephropathy (33 patients) and with diabetic nephropathy (32 patients), 64 patients with diabetes lasting more than 10-20 years, with no diabetic nephropathy (31 patients ) and diabetic nephropathy (33 patients). Genotyping was carried out using the polymerase chain reaction method. The study showed that the association of the D allele and the heterozygous I/D genotype of the ACE gene play a role in the development of diabetic nephropathy in patients with type 2 diabetes mellitus in the studied Uzbek nation
Keywords
##plugins.themes.academic_pro.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
- Dedov I.I., Shestakova M.V., ed. Complications of diabetes mellitus. Treatment and prevention. M .: MIA; 2017.83 p.
- Dedov I.I., Shestakova M.V., ed. Diabetes. Acute and chronic complications. M.: MIA; 2011.197p.
- Jeleznyakova AV, Lebedeva NO, Vikulova OK, et al. The risk of developing chronic kidney disease in patients with type 2 diabetes is determined by polymorphism of the NOS3, APOB, KCNJ11, TCF7L2 genes // Diabetes mellitus. 2014. No. 3. PP. 23-30.
- Jabborov O.O. Genetic factors of diabetic nephropatia in patients with type 2 diabetes mellitus // Global journal of medical research. No.1, 2019. PP. 1-7
- Jabborov O.O. Features of Genetic polymorphism in population with diabetic nephropathia: Literature review // Journal of advances in medicine and medical research No. 29(9), 2019: PP. 1-7.
- Jabbarov O.O. Significance of the RAAS coding component of the ACE gene in the development of diabetic nephropathy in type 2 diabetes // Infection, immunity and pharmacology. No.6, 2019. PP. 47-55
- Ezzidi I., Mtiraoui N., Kacem M. et.al. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy // Diabetes / Metabolism Research and Reviews. 2009. Vol. 25, no.8. P. 717-724.
- Morshed M., Khan H., Akhteruzzaman S. Association between angiotensin I-converting enzyme gene polymorphism and hypertension in selected individuals in the Bangladeshi population // Journal of Biochemistry and Molecular Biology. 2002. Vol. 35, no. 3. P. 251-254.
- Settin A., Elbaz R., Abbas A., et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Egyptian patients with myocardial infarction // Journal of the Renin-Angiotensin-Aldosterone System. 2009. No. 10. R. 96-100.
- Sauca O.E., Carpini S.D., Zagato L., et.al. Role of angiotensin-converting enzyme insertion / deletion polymorphism in type 1 diabetes nephropathy. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2012. Vol. 19, no. 2. P. 143-149.
- Shanmuganathan R., Kumaresan R., Giri P. Prevalence of angiotensin converting enzyme (ACE) gene insertion / deletion polymorphism in South Indian population with hypertension and chronic kidney disease // Journal of Postgraduate Medicine. 2015. Vol. 61, no. 4. P. 230-234.
- Uddin M., Azam M., Chowdhury N., et al. Angiotensin I-Converting Enzyme Gene Polymorphism in Type 2 Diabetic Patients with Nephropathy // Journal of Medical Sciences. 2007. No. 7. P. 682-685.
- Yu Z.Y., Chen L.S., Zhang L.C., et. al. Metaanalysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy // Nephrology. 2012. Vol. 17, no. 5. P. 480.